Cardiac-specific overexpression of GTP cyclohydrolase 1 restores ischaemic preconditioning during hyperglycaemia.

AIMS Hyperglycaemia (HG) decreases intracellular tetrahydrobiopterin (BH(4)) concentrations, and this action may contribute to injury during myocardial ischaemia and reperfusion. We investigated whether increased BH(4) by cardiomyocyte-specific overexpression of the GTP cyclohydrolase (GTPCH) 1 gene rescues myocardial and mitochondrial protection by ischaemic preconditioning (IPC) during HG through a nitric oxide (NO)-dependent pathway. METHODS AND RESULTS Mice underwent 30 min of myocardial ischaemia followed by 2 h of reperfusion with or without IPC elicited with four cycles of 5 min ischaemia/5 min of reperfusion in the presence or absence of HG produced by d-glucose. In C57BL/6 wild-type mice, IPC increased myocardial BH(4) and NO concentrations and decreased myocardial infarct size (30 ± 3% of risk area) compared with control (56 ± 5%) experiments. This protective effect was inhibited by HG (48 ± 3%) but not hyperosmolarity. GTPCH-1 overexpression increased myocardial BH(4) and NO concentrations and restored cardioprotection by IPC during HG (32 ± 4%). In contrast, a non-selective NO synthase inhibitor N(G)-nitro-l-arginine methyl ester attenuated the favourable effects of GTPCH-1 overexpression (52 ± 3%) during HG. Mitochondria isolated from myocardium subjected to IPC required significantly higher in vitro Ca(2+) concentrations (184 ± 14 µmol mg(-1) protein) to open the mitochondrial permeability transition pore when compared with mitochondria isolated from control experiments (142 ± 10 µmol mg(-1) protein). This beneficial effect of IPC was reversed by HG and rescued by GTPCH-1 overexpression. CONCLUSION Increased BH(4) by cardiomyocyte-specific overexpression of GTPCH-1 preserves the ability of IPC to elicit myocardial and mitochondrial protection that is impaired by HG, and this action appears to be dependent on NO.

[1]  Dharini van der Hoeven,et al.  A(3) adenosine receptor activation during reperfusion reduces infarct size through actions on bone marrow-derived cells. , 2010, Journal of molecular and cellular cardiology.

[2]  N. Alp,et al.  Cardiac myocyte-specific overexpression of human GTP cyclohydrolase I protects against acute cardiac allograft rejection. , 2010, American journal of physiology. Heart and circulatory physiology.

[3]  P. Pratt,et al.  Hyperglycemia Adversely Modulates Endothelial Nitric Oxide Synthase during Anesthetic Preconditioning through Tetrahydrobiopterin– and Heat Shock Protein 90–mediated Mechanisms , 2010, Anesthesiology.

[4]  P. Pratt,et al.  Isoflurane Postconditioning Protects against Reperfusion Injury by Preventing Mitochondrial Permeability Transition by an Endothelial Nitric Oxide Synthase–dependent Mechanism , 2010, Anesthesiology.

[5]  R. Migrino,et al.  Sepiapterin Decreases Acute Rejection and Apoptosis in Cardiac Transplants Independently of Changes in Nitric Oxide and Inducible Nitric-Oxide Synthase Dimerization , 2009, Journal of Pharmacology and Experimental Therapeutics.

[6]  Yajing Wang,et al.  AMP-Activated Protein Kinase Deficiency Enhances Myocardial Ischemia/Reperfusion Injury but Has Minimal Effect on the Antioxidant/Antinitrative Protection of Adiponectin , 2009, Circulation.

[7]  J. Krolikowski,et al.  Role of Heat Shock Protein 90 and Endothelial Nitric Oxide Synthase during Early Anesthetic and Ischemic Preconditioning , 2009, Anesthesiology.

[8]  J. Vasquez-Vivar,et al.  Deficient BH4 production via de novo and salvage pathways regulates NO responses to cytokines in adult cardiac myocytes. , 2008, American journal of physiology. Heart and circulatory physiology.

[9]  Y. Yoon,et al.  Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. , 2008, Cardiovascular research.

[10]  P. Pagel,et al.  Simvastatin Restores Ischemic Preconditioning in the Presence of Hyperglycemia through a Nitric Oxide–mediated Mechanism , 2008, Anesthesiology.

[11]  P. Raskin,et al.  Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. , 2008, Circulation.

[12]  R. Bolli,et al.  Endothelial nitric oxide synthase is not necessary for the early phase of ischemic preconditioning in the mouse. , 2008, Journal of molecular and cellular cardiology.

[13]  J. Zweier,et al.  Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4 , 2007, Proceedings of the National Academy of Sciences.

[14]  D. Yellon,et al.  Myocardial reperfusion injury. , 2007, The New England journal of medicine.

[15]  A. Hsu,et al.  Diabetes Abolishes Morphine-Induced Cardioprotection via Multiple Pathways Upstream of Glycogen Synthase Kinase-3β , 2007, Diabetes.

[16]  G. Gross,et al.  Cl-IB-MECA [2-Chloro-N6-(3-iodobenzyl)adenosine-5′-N-methylcarboxamide] Reduces Ischemia/Reperfusion Injury in Mice by Activating the A Adenosine Receptor , 2006, Journal of Pharmacology and Experimental Therapeutics.

[17]  Steven P Jones,et al.  The ubiquitous role of nitric oxide in cardioprotection. , 2006, Journal of molecular and cellular cardiology.

[18]  K. Rockett,et al.  Stoichiometric Relationships Between Endothelial Tetrahydrobiopterin, Endothelial NO Synthase (eNOS) Activity, and eNOS Coupling in Vivo: Insights From Transgenic Mice With Endothelial-Targeted GTP Cyclohydrolase 1 and eNOS Overexpression , 2005, Circulation research.

[19]  X. Leverve,et al.  Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process. , 2005, Diabetes.

[20]  K. Channon,et al.  Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells. , 2005, Cardiovascular research.

[21]  K. Channon,et al.  GTP cyclohydrolase I gene transfer reverses tetrahydrobiopterin deficiency and increases nitric oxide synthesis in endothelial cells and isolated vessels from diabetic rats , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  A. Tsai,et al.  Three Different Oxygen-induced Radical Species in Endothelial Nitric-oxide Synthase Oxygenase Domain under Regulation by L-Arginine and Tetrahydrobiopterin* , 2004, Journal of Biological Chemistry.

[23]  DerekHausenloy,et al.  Transient Mitochondrial Permeability Transition Pore Opening Mediates Preconditioning-Induced Protection , 2004 .

[24]  M. Castro,et al.  Role of nitric oxide in thermoregulation during septic shock: involvement of vasopressin , 2003, Pflügers Archiv.

[25]  K. Nishioka,et al.  Effect of acute hyperglycemia on the ischemic preconditioning effect of prodromal angina pectoris in patients with a first anterior wall acute myocardial infarction. , 2003, The American journal of cardiology.

[26]  L. Køber,et al.  Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects. , 2003, American journal of physiology. Heart and circulatory physiology.

[27]  D. Harrison,et al.  Interactions of Peroxynitrite, Tetrahydrobiopterin, Ascorbic Acid, and Thiols , 2003, Journal of Biological Chemistry.

[28]  T. Bohlen,et al.  Effect of acute hyperglycaemia and diabetes mellitus with and without short-term insulin treatment on myocardial ischaemic late preconditioning in the rabbit heart in vivo , 2003, Pflügers Archiv.

[29]  Y. Hattori,et al.  HMG-CoA Reductase Inhibitor Increases GTP Cyclohydrolase I mRNA and Tetrahydrobiopterin in Vascular Endothelial Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[30]  D. Harrison,et al.  Uncoupling of eNOS by ONOO-1 Interactions of peroxynitrite , tetrahydrobiopterin , ascorbic acid and thiols : Implications for uncoupling endothelial nitric oxide synthase , 2003 .

[31]  S. Verma,et al.  Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation. , 2002, The Journal of thoracic and cardiovascular surgery.

[32]  P. Pagel,et al.  Hyperglycemia Prevents Isoflurane-induced Preconditioning against Myocardial Infarction , 2002, Anesthesiology.

[33]  D. Yellon,et al.  The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice. , 2001, Cardiovascular research.

[34]  D. Stuehr,et al.  Oxygen Reduction by Nitric-oxide Synthases* , 2001, The Journal of Biological Chemistry.

[35]  P. Pagel,et al.  Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels. , 2001, American journal of physiology. Heart and circulatory physiology.

[36]  P. Bernardi,et al.  Opening of the Mitochondrial Permeability Transition Pore Causes Depletion of Mitochondrial and Cytosolic NAD+and Is a Causative Event in the Death of Myocytes in Postischemic Reperfusion of the Heart* , 2001, The Journal of Biological Chemistry.

[37]  C. Cooper,et al.  Nitric oxide synthases: structure, function and inhibition. , 2001, The Biochemical journal.

[38]  R. Bolli The Late Phase of Preconditioning , 2000, Circulation research.

[39]  T. Meinertz,et al.  Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus , 2000, Diabetologia.

[40]  J. Downey,et al.  Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. , 2000, Journal of molecular and cellular cardiology.

[41]  P. Pagel,et al.  Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. , 2000, American journal of physiology. Heart and circulatory physiology.

[42]  N. Blau,et al.  Tetrahydrobiopterin biosynthesis, regeneration and functions. , 2000, The Biochemical journal.

[43]  B. Mayer,et al.  Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase. , 2000, Circulation research.

[44]  J. Downey,et al.  Ischemic preconditioning: from adenosine receptor to KATP channel. , 2000, Annual review of physiology.

[45]  Z. Szilvássy,et al.  Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts. , 1999, Circulation.

[46]  K. Pritchard,et al.  Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[47]  P. Pagel,et al.  Acute hyperglycemia abolishes ischemic preconditioning in vivo. , 1998, The American journal of physiology.

[48]  J. Kastelein,et al.  Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. , 1997, The Journal of clinical investigation.

[49]  D. Yellon,et al.  Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. , 1995, Circulation.

[50]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.